Actavis Belgium
News Tout Produit Engagement Autres Year Tout 2012 2011 2010 2009
• Création du 3ème laboratoire génériqueur au monde • ~8 milliards de dollars de Chiffre d’Affaires attendus en 2012 • Augmentation significative de la taille du business générique en
Global managed-care offering to help bring down treatment costs for 366 million diabetics Actavis and Bioton (WSE:BIO) announced today that they have formed a joint venture company for the
Actavis Group, the international generic pharmaceuticals company, has acquired 100% of the shares in PharmaPack International B.V. for an undisclosed amount. PharmaPack is based in Zoetermeer,